KeyBanc Maintains Overweight Rating on Microsoft Highlighting Cloud and AI Momentum BristolMyers Squibb BMY Draws Hedge Fund Attention with 425 Dividend Yield and AI Partnership Jeff Bezos Proposes Zero Federal Income Tax for Some Americans A Potential Shift in Tax Policy Discourse Nvidia Stock Approaches Critical Technical Level Amid Market Scrutiny Latin American Leaders Seek New Housing Finance and Climate Resilience at World Urban Forum 13 Micron Stock Surges After UBS Triples Price Target Sees AIDriven Transformation JOE Q1 2026 Earnings EPS of 024 Reported Stock Declines Slightly KLAR Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Response Lineage Cell Therapeutics Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Continues Pipeline Investment NOA Q1 2026 Earnings EPS Slightly Below Estimates Stock Edges Higher ICU Medical Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operational Performance Immunovant IMVT Edges Lower Amid Consolidation Support and Resistance Levels in Focus Starry Sea Acquisition Corp SSEA Holds Steady Near Trust Value Potential Catalyst Ahead Intuitive Surgical ISRG Edges Higher as This Key Support Level Holds Valvoline Inc VVV Gains 108 as Shares Approach Midpoint of Trading Range Westlake Chemical Partners WLKP Edges Higher Amid Steady Volume and Stable Support Levels Tata Sons Board to Review Strategy Amid Leadership Tensions and Investment Push OXLCZ Q4 2025 Earnings EPS Misses Estimates as Net Investment Income Falls Short Taiwan Semiconductor TSM Rises 18 as AI Momentum Drives Investor Interest UAVS Q3 2023 Earnings EPS Beats Estimate Amid Revenue Absence Stock Surges 505 OPRX Q1 2026 Earnings Massive EPS Beat Driven by Strong Operational Performance FUBO Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher Limoneira LMNR Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures Stock Eases FCAP Q1 2026 Earnings Solid EPS of 130 Drives Modest Stock Gain GEL Q1 2026 Earnings EPS Misses Estimates as Partnership Reports Unexpected Loss ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Continued Clinical Progress